Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: ErbB2-Positive Stage I-III Breast Cancer
Interventions: DRUG: paclitaxel/carboplatin/lapatinib
Sponsor: National University Hospital, Singapore
Collaborators: National Cancer Centre, Singapore